Cargando…

Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study

BACKGROUND: Patients with advanced cancer do receive increasingly aggressive end-of-life care, despite it does often not prolong survival time but entails decreased quality of life for patients. This qualitative study explores the unfolding of aggressive end-of-life care in clinical practice focusin...

Descripción completa

Detalles Bibliográficos
Autores principales: Haun, Markus W., Wildenauer, Alina, Hartmann, Mechthild, Bleyel, Caroline, Becker, Nikolaus, Jäger, Dirk, Friederich, Hans-Christoph, Tönnies, Justus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539079/
https://www.ncbi.nlm.nih.gov/pubmed/36212451
http://dx.doi.org/10.3389/fonc.2022.870431
_version_ 1784803428773396480
author Haun, Markus W.
Wildenauer, Alina
Hartmann, Mechthild
Bleyel, Caroline
Becker, Nikolaus
Jäger, Dirk
Friederich, Hans-Christoph
Tönnies, Justus
author_facet Haun, Markus W.
Wildenauer, Alina
Hartmann, Mechthild
Bleyel, Caroline
Becker, Nikolaus
Jäger, Dirk
Friederich, Hans-Christoph
Tönnies, Justus
author_sort Haun, Markus W.
collection PubMed
description BACKGROUND: Patients with advanced cancer do receive increasingly aggressive end-of-life care, despite it does often not prolong survival time but entails decreased quality of life for patients. This qualitative study explores the unfolding of aggressive end-of-life care in clinical practice focusing on the decision-making process and the quality of end-of-life care from family members’ perspective. MATERIALS AND METHODS: We conducted semi-structured interviews with 16 family members (six of cancer patients with and ten without aggressive end-of-life care) at the National Center for Tumor Diseases Heidelberg, Germany. We conducted a content analysis applying a theoretical framework to differentiate between ‘decision-making’ (process of deciding for one choice among many options) and ‘decision-taking’ (acting upon this choice). RESULTS: While patients of the aggressive care group tended to make and take decisions with their family members and physicians, patients of the other group took the decision against more aggressive treatment alone. Main reason for the decision in favor of aggressive care was the wish to spend more time with loved ones. Patients took decisions against aggressive care given the rapid decline in physical health and to spare relatives difficult decisions and arising feelings of guilt and self-reproach. CONCLUSION: Treatment decisions at end-of-life are always individual. Nevertheless, treatment courses with aggressive end-of-life care and those without differ markedly. To account for a longitudinal perspective on the interplay between patients, family members, and physicians, cohort studies are needed. Meanwhile, clinicians should validate patients and family members considering refraining from aggressive end-of-life care and explore their motives. CLINICAL TRIAL REGISTRATION: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022837, identifier DRKS00022837.
format Online
Article
Text
id pubmed-9539079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95390792022-10-08 Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study Haun, Markus W. Wildenauer, Alina Hartmann, Mechthild Bleyel, Caroline Becker, Nikolaus Jäger, Dirk Friederich, Hans-Christoph Tönnies, Justus Front Oncol Oncology BACKGROUND: Patients with advanced cancer do receive increasingly aggressive end-of-life care, despite it does often not prolong survival time but entails decreased quality of life for patients. This qualitative study explores the unfolding of aggressive end-of-life care in clinical practice focusing on the decision-making process and the quality of end-of-life care from family members’ perspective. MATERIALS AND METHODS: We conducted semi-structured interviews with 16 family members (six of cancer patients with and ten without aggressive end-of-life care) at the National Center for Tumor Diseases Heidelberg, Germany. We conducted a content analysis applying a theoretical framework to differentiate between ‘decision-making’ (process of deciding for one choice among many options) and ‘decision-taking’ (acting upon this choice). RESULTS: While patients of the aggressive care group tended to make and take decisions with their family members and physicians, patients of the other group took the decision against more aggressive treatment alone. Main reason for the decision in favor of aggressive care was the wish to spend more time with loved ones. Patients took decisions against aggressive care given the rapid decline in physical health and to spare relatives difficult decisions and arising feelings of guilt and self-reproach. CONCLUSION: Treatment decisions at end-of-life are always individual. Nevertheless, treatment courses with aggressive end-of-life care and those without differ markedly. To account for a longitudinal perspective on the interplay between patients, family members, and physicians, cohort studies are needed. Meanwhile, clinicians should validate patients and family members considering refraining from aggressive end-of-life care and explore their motives. CLINICAL TRIAL REGISTRATION: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022837, identifier DRKS00022837. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9539079/ /pubmed/36212451 http://dx.doi.org/10.3389/fonc.2022.870431 Text en Copyright © 2022 Haun, Wildenauer, Hartmann, Bleyel, Becker, Jäger, Friederich and Tönnies https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Haun, Markus W.
Wildenauer, Alina
Hartmann, Mechthild
Bleyel, Caroline
Becker, Nikolaus
Jäger, Dirk
Friederich, Hans-Christoph
Tönnies, Justus
Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title_full Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title_fullStr Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title_full_unstemmed Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title_short Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
title_sort negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – a qualitative interview study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539079/
https://www.ncbi.nlm.nih.gov/pubmed/36212451
http://dx.doi.org/10.3389/fonc.2022.870431
work_keys_str_mv AT haunmarkusw negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT wildenaueralina negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT hartmannmechthild negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT bleyelcaroline negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT beckernikolaus negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT jagerdirk negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT friederichhanschristoph negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy
AT tonniesjustus negotiatingdecisionsonaggressivecancercareatendoflifebetweenpatientsfamilymembersandphysiciansaqualitativeinterviewstudy